Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection
about
TLR4 and NKT cell synergy in immunotherapy against visceral leishmaniasisIdentification of novel Leishmania donovani antigens that help define correlates of vaccine-mediated protection in visceral leishmaniasisComparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis.Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesionsBALB/c mice deficient in CD4 T cell IL-4Rα expression control Leishmania mexicana Load although female but not male mice develop a healer phenotypeAnimal models for the study of leishmaniasis immunology.Clinical and experimental advances in treatment of visceral leishmaniasis.Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants.Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasisInterleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.Deception and manipulation: the arms of leishmania, a successful parasiteLeishmania mexicana induces limited recruitment and activation of monocytes and monocyte-derived dendritic cells early during infectionInterleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathologyImmunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis.Role of co-stimulation in LeishmaniasisT helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant?Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model.The cell surface receptor SLAM controls T cell and macrophage functionsImmune response regulation by leishmania secreted and nonsecreted antigens.Overexpression of the natural inhibitor of cysteine peptidases in Leishmania mexicana leads to reduced virulence and a Th1 responseRole of chemokines in regulation of immunity against leishmaniasis.Cytokines and their STATs in cutaneous and visceral leishmaniasis.Both interleukin-4 (IL-4) and IL-4 receptor alpha signaling contribute to the development of hepatic granulomas with optimal antileishmanial activity.T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.Expression of multiple CPB genes encoding cysteine proteases is required for Leishmania mexicana virulence in vivo.Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13.A Novel Sterol Isolated from a Plant Used by Mayan Traditional Healers Is Effective in Treatment of Visceral Leishmaniasis Caused by Leishmania donovani.Visceral Leishmania donovani infection in interleukin-13-/- mice.IL-4-deficient Balb/c mice resist infection with Leishmania major.A Leishmania infantum cytosolic tryparedoxin activates B cells to secrete interleukin-10 and specific immunoglobulin.Interleukin-4 Receptor Alpha: From Innate to Adaptive Immunity in Murine Models of Cutaneous Leishmaniasis.Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response
P2860
Q27346402-30DFE4E7-68F2-4DCE-830B-3965B79DEC9EQ33463435-6A101CB1-7F67-4733-ABBD-284FA657EA60Q33615236-C0F65D1D-E6A4-4B83-8D5B-17FD603B32BFQ33769299-5AA97916-E38F-4CC8-BD9E-D9F1513C0A38Q33796509-F4C115BE-B893-4566-A073-B28BD3EDC160Q33859617-D831E15E-5D6F-4FCD-A521-FAB4532FCF69Q33982648-961B4483-27A7-4FAE-A799-B02F0BDBFB08Q34003547-EACE84B4-5060-4A49-80B7-A1979E70FBD7Q34008441-21AB1B8D-F059-4804-87EC-05F709E1FA88Q34181985-99C20F14-CC66-46AE-8AD0-89FF3569BE2EQ34369161-7C70A415-340B-471E-99A1-770C65AF5EFDQ34456673-16CE793A-CBEA-4F3B-837E-679D72E569B1Q35070810-A122C171-420B-4C36-808E-04A07A988BF9Q35165825-346CB68F-9D14-4130-BC2F-2277581D7C1BQ35566850-A5F5BF13-A4F7-4CB2-908D-062EF4FA2FC9Q35928348-0438BF46-ECF6-4E4E-81C7-49F6BA10BD01Q36376855-A3651DFE-30CD-4948-9F5C-4E0802275A89Q36399495-A187209D-5272-4159-BAA1-3D754EB14E22Q36915063-3B16E8C7-7393-4F72-A414-F485CB31552DQ37256460-9D8814DC-BAC4-49E8-AD17-E796CE5BA9D7Q37703644-47A9448D-3B99-4D68-959E-087F3A25E20CQ37714367-A454EB5A-A03F-495E-80C1-1E1121F2932EQ39495279-B500DD54-96F3-49DD-BB12-1B70823DBF50Q39518100-A3BFA750-9BE3-48E3-B90D-1D5E0D91415DQ39755109-BA1979DC-328B-4B5A-832C-A4F03C4B5E11Q40073796-E298D834-8457-456F-9330-FF5712A3AAA8Q40541880-865D34EC-F4A3-4787-8B23-2709513C5C46Q42049818-94254A92-8007-4412-8187-809D6DB27BEDQ42943751-CCA2FC7F-0E72-4F92-A75F-F4FA8B307A4CQ46889693-198F84A5-4C40-49E0-A39F-C5A2D13DBF39Q47156219-CC8E7150-F464-4565-BA3F-01B579CBB63CQ58836359-1A72AB0F-7FD0-4C09-8E60-E63BF7D791E3
P2860
Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection
description
1995 nî lūn-bûn
@nan
1995 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Disruption of the murine inter ...... Leishmania donovani infection
@ast
Disruption of the murine inter ...... Leishmania donovani infection
@en
type
label
Disruption of the murine inter ...... Leishmania donovani infection
@ast
Disruption of the murine inter ...... Leishmania donovani infection
@en
prefLabel
Disruption of the murine inter ...... Leishmania donovani infection
@ast
Disruption of the murine inter ...... Leishmania donovani infection
@en
P2093
P2860
P1476
Disruption of the murine inter ...... Leishmania donovani infection
@en
P2093
Alexander J
Bluethmann H
Satoskar A
P2860
P304
P407
P577
1995-12-01T00:00:00Z